Summary by Futu AI
Mark Mortenson, Chief Science Officer of Clene Inc. [CLNN], completed a purchase of 20,512 shares of common stock on September 30, 2024. The transaction was carried out on the open market at a price of $4.75 per share, resulting in a total investment of $97,432. Mortenson's direct holdings in the company increased to 28,949 shares following the transaction.